Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1517434 | 0.83 | MEN1 (0.36) | RIPK1TSHR | |
| SCHEMBL21925346 | 0.83 | — | — | |
| SCHEMBL8949649 | 0.81 | LMNA (0.36) | RIPK1 | |
| SCHEMBL18993461 | 0.80 | TSHR (0.43) | RIPK1TSHRTDP1 | |
| SCHEMBL4900666 | 0.79 | LMNA (0.35) | — | |
| SCHEMBL26106413 | 0.79 | MEN1 (0.31) | — | |
| SCHEMBL1872786 | 0.79 | LMNA (0.35) | — | |
| SCHEMBL21103849 | 0.78 | — | — | |
| SCHEMBL17117833 | 0.78 | GRM4 (0.31) | — | |
| SCHEMBL21925317 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062631-A1 | CYCLOOCTANE CONTAINING FUEL COMPOSITIONS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2026-03-05 | — | — | US | claimed |
| EP-2829555-B1 | METHOD FOR PRODUCING OLEFIN POLYMER | MITSUI CHEMICALS INC (JP) | 2018-05-16 | — | — | EP | claimed |
| CN-104203993-B | Process for producing olefin polymer | 三井化学株式会社 | 2016-06-15 | — | — | CN | claimed |
| US-9315602-B2 | Method for producing olefin polymer | MITSUI CHEMICALS, INC. (JP) | 2016-04-19 | — | — | US | claimed |
| WO-2004024818-A1 | POLYOXYMETHYLENE COMPOSITIONS CONTAINING SELECTED FORMALDEHYDE SCAVENGERS AND THE USE THEREOF | TICONA GMBH (DE) | 2004-03-25 | — | — | WO | claimed |
| EP-1084157-A1 | METHOD FOR HYDROGENATING AROMATIC POLYMERS IN THE PRESENCE OF BRANCHED HYDROCARBONS | Bayer Aktiengesellschaft (DE) | 2001-03-21 | — | — | EP | claimed |
| WO-1999052953-A1 | METHOD FOR HYDROGENATING AROMATIC POLYMERS IN THE PRESENCE OF BRANCHED HYDROCARBONS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-10-21 | — | — | WO | claimed |
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260062631-A1 | CYCLOOCTANE CONTAINING FUEL COMPOSITIONS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2026-03-05 | — | — | US | disclosed |
| US-12503662-B1 | Cyclooctane containing seal swelling compositions and methods for use of same | CleanJoule, Inc. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250152646-A1 | SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING CANNABINOIDS FROM PLANTS EXTRACTS OR FROM SYNTHETIC PATHWAYS | NOEL ARMAND J (US) | 2025-05-15 | — | — | US | disclosed |
| US-12090185-B2 | Processes for converting cannabinoids into cannabinoid derivatives and recovering the same | SUPER CRITICAL IP, LLC (US) | 2024-09-17 | — | — | US | disclosed |
| EP-3907003-B1 | HALOGEN-CONTAINING COMPOUND AND USE THEREOF AS CATALYST LIGAND IN ETHYLENE OLIGOMERIZATION | CHINA PETROLEUM & CHEM CORP (CN) | 2024-09-04 | — | — | EP | disclosed |
| WO-2003063771-A2 | N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS | PHARMASSET LTD. (BB) | 2003-08-07 | — | — | WO | disclosed |
| WO-2003051298-A2 | PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051306-A2 | N4-ACYLCYTOSINE-1,3-DIOXOLANE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS | PHARMASSET LTD. (BB) | 2003-06-26 | — | — | WO | disclosed |
| US-6331519-B1 | MIXING POLYETHYLENIMINE FORMED BY PARTIAL HYDROLYSIS OF OLIGO/POLYVINYLFORMAMIDES WITH DI- OR POLYCARBOXYLIC ACID OR SALT; COLOR TEXTILES, COTTON | BASF AKTIENGESELLSCHAFT (DE) | 2001-12-18 | — | — | US | disclosed |
| EP-1084157-A1 | METHOD FOR HYDROGENATING AROMATIC POLYMERS IN THE PRESENCE OF BRANCHED HYDROCARBONS | Bayer Aktiengesellschaft (DE) | 2001-03-21 | — | — | EP | disclosed |
| WO-1999052953-A1 | METHOD FOR HYDROGENATING AROMATIC POLYMERS IN THE PRESENCE OF BRANCHED HYDROCARBONS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-10-21 | — | — | WO | disclosed |
| EP-0609587-A2 | Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract | NYCOMED IMAGING AS (NO) | 1994-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | CNR2, CNR1, SCD | RIPK1 1891/4885TSHR 2794/4885TDP1 4427/4885 |
| US-12503662-B1 | Cyclooctane containing seal swelling compositions and methods for use of same | AQP1, GJA1, DSC1 | RIPK1 3001/4885TSHR 4878/4885TDP1 1783/4885 |
| US-20260062631-A1 | CYCLOOCTANE CONTAINING FUEL COMPOSITIONS | CPT1A, CPT2, CNR2 | RIPK1 3373/4885TSHR 3620/4885TDP1 1781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.